Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|February 23, 2023
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trialsBeatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, et al.
Chimia|December 9, 2023
Current HDAC Inhibitors in Clinical TrialsElisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.
Chemmedchem|March 26, 2024
Uracil- and Pyridine-Containing HDAC Inhibitors Displayed Cytotoxicity in Colorectal and Glioblastoma Cancer Stem CellsFrancesco Fiorentino, Emanuele Fabbrizi, Alessia Raucci, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 23, 2022
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activityRossella Fioravanti, Veronica Rodriguez, Jonatan Caroli, et al.
ACS Infectious Diseases|June 22, 2022
Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoniElisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.
Journal of Medicinal Chemistry|March 5, 2025
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB InhibitorBeatrice Noce, Sara Marchese, Marta Massari, et al.
Chemmedchem|October 17, 2022
Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult StagesBeatrice Noce, Elisabetta Di Bello, Clemens Zwergel, et al.
European Journal of Medicinal Chemistry|December 22, 2022
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cellsElisabetta Di Bello, Veronica Sian, Giulio Bontempi, et al.
Nature Chemical Biology|October 26, 2023
Targeting ROS production through inhibition of NADPH oxidasesJoana Reis, Christoph Gorgulla, Marta Massari, et al.
Pageof 2